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Abstract
Background: Prolonged weaning from mechanical ventilation has a major impact on ICU bed occupancy and
patient outcome, and has significant cost implications.
There is evidence in patients around the period of extubation that helium-oxygen leads to a reduction in the work
of breathing. Therefore breathing helium-oxygen during weaning may be a useful adjunct to facilitate weaning.
We hypothesised that breathing helium-oxygen would reduce carbon dioxide production during the weaning
phase of mechanical ventilation.
Materials/patients and methods: We performed a prospective randomised controlled single blinded cross-over
trial on 19 adult intensive care patients without significant airways disease who fulfilled criteria for weaning with
CPAP. Patients were randomised to helium-oxygen and air-oxygen delivered during a 2 hour period of CPAP
ventilation. Carbon dioxide production (VCO2) was measured using a near patient main stream infrared carbon
dioxide sensor and fixed orifice pneumotachograph.
Results: Compared to air-oxygen, helium-oxygen significantly decreased VCO2 production at the end of the 2 hour
period of CPAP ventilation; there was a mean difference in CO2 production of 48.9 ml/min (95% CI 18.7-79.2
p = 0.003) between the groups. There were no significant differences in other respiratory and haemodynamic
parameters.
Conclusion: This study shows that breathing a helium-oxygen mixture during weaning reduces carbon dioxide
production. This physiological study supports the need for a clinical trial of helium-oxygen mixture during the
weaning phase of mechanical ventilation with duration of weaning as the primary outcome.
Trial registration: ISRCTN56470948
Introduction
Weaning from mechanical ventilation is estimated to
account for up to 40% of the total duration of ventila-
tory support [1]. The process of weaning patients there-
fore has a major impact on ICU bed occupancy with
significant cost implication [2]. Strategies to facilitate
weaning have a major potential to reduce use of health-
care resources [3,4].
Helium is an inert gas and prolonged administration
to animals has demonstrated no adverse effects [5].
Helium has a lower density and higher viscosity com-
pared with oxygen and nitrogen. Breathing helium leads
to a decreased resistance in gas flow, a change from tur-
bulent to laminar flow patterns [6] and a reduction in
the work of breathing. However a change from turbu-
lent to laminar flow patterns is unnecessary for the
reduction in the work of breathing which can occur
under fully turbulent flow [7].
Helium-oxygen has been used in clinical situations
where upper or lower airways obstruction or disease
leads to an increased resistance to flow. Although there
are many case reports of successful use of helium-oxygen
in these conditions, to date no studies have conclusively * Correspondence: Gordon.Flynn@sesiahs.health.nsw.gov.au
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groups [8].
There are limited data regarding the use of helium-
oxygen during weaning. Use of a helium-oxygen mixture
during weaning with CPAP has been successfully used
to improve respiratory distress and improve PaO2 after
cardiovascular surgery in a small study in infants [9]. In
addition, in ventilated patients with airflow obstruction,
breathing helium-oxygen during a T-piece breathing
trial just prior to extubation resulted in a reduction in
airway resistance and consequently a decrease in work
of breathing [10].
The aim of this physiological study was to determine
whether breathing a helium-oxygen mixture as com-
pared with an air-oxygen mixture during the weaning
phase of mechanical ventilation would reduce carbon
dioxide production in patients without significant
airways obstruction.
Materials and methods
We conducted a prospective single centre, randomised,
single blinded, controlled, cross-over study in our 18
bed mixed medical-surgical ICU. Approval for the study
was obtained from Research Ethics Committee and the
Medicines and Health Regulatory Agency (MHRA).
Eligible patients were ready for weaning to CPAP and
had to meet the following inclusion criteria; the underly-
ing cause of respiratory failure was improving, pressure
support ventilation of less than 10 cmH2O, no continu-
ous intravenous sedation or inotropes, FiO2 less than or
equal to 0.4 and requiring less than 10 cmH2O positive
end expiratory pressure. Written informed consent from
the patient or assent from their next of kin was
obtained.
Respiratory parameters were measured using a near
patient main stream infrared carbon dioxide sensor and
fixed orifice pneumotachograph connected to a respira-
tory profile monitor (CO2SMO Plus Respiratory Monitor,
Novametrix Medical systems, Wallingford, CT, USA) and
analysed using computer software (Analysis plus). The
capnograph is barometric pressure compensated with an
accuracy of +/- 2 mmHg (for 0 - 40 mmHg) and +/- 5%
of the reading (for 41 - 70 mmHg). The pneumotacho-
graph is a disposable device using differential pressure
with an overall accuracy of +/-2%. This device was cali-
brated for the specific fraction of inspired helium and
oxygen on an individual patient basis according to the
manufacturer’s instructions. On initialisation the device
performs a zero calibration. The accuracy of the infrared
carbon dioxide sensor is further verified by using a cali-
bration device for carbon dioxide. Furthermore a pre-
vious study showed the monitoring device remained
stable and accurate over a 48 hour period of continuous
monitoring[11]. Alveolar minute ventilation, respiratory
rate and CO2 production were continuously recorded by
the CO2SMO plus monitor. Representative base line
carbon dioxide production in a 70 kg male is 200 ml/
min. An average of a 5 minute period of these parameters
was recorded before the start of CPAP as a baseline and
at 1 and 2 hours during each CPAP period with the study
gases. Systolic and diastolic blood pressure and heart rate
were recorded directly by means of an indwelling arterial
catheter and electrocardiogram (ECG) attached to a bed-
side monitor. Arterial partial pressure of carbon dioxide
and oxygen were obtained over a 2-hour period from
arterial blood gas samples.
Patients were randomly assigned to initially breath
either Heliox or air-oxygen mixtures. Patients were
blinded to the gas mixture they received. Data was col-
lected directly to a laptop computer and the researcher
and study statistician who analysed the data were
blinded to the gas mixtures. Following baseline measure-
ments, patients received 2 hours of CPAP ventilation
(PEEP setting remained unchanged and pressure support
set to zero) with helium-oxygen or air-oxygen via an
eVent ventilator (eVent Medical Inc. 81 Columbia Suite
101, Aliso Viejo, CA 92656). This ventilator was cali-
brated for the helium oxygen mixture on an individual
patient basis according to the manufacturer’si n s t r u c -
tions. Patients were returned to their pre study ventila-
tor settings for 2 hours, before being given the
alternative gas mixture for 2 hours.
The level of CPAP support and FiO2 were unchanged
for individual patients throughout the trial period. The
study CPAP trial was defined as unsuccessful and dis-
continued if the patients developed two or more of the
following criteria: respiratory rate > 40 breaths/min or
rapid shallow breathing index (RSBI) > 105; SpO2 <90%
or SpO2 decrease to >8% from the patients baseline
value; HR > 140 beats/min or HR changes by >20%
from the patients baseline; systolic blood pressure >200
mmHg or < 80 mmHg or systolic blood pressure
changes by >20% of baseline; deterioration in conscious
level, defined as a fall in GCS of >2, or if the patient
became agitated/sweating/anxious.
The data were tested for normality and a paired t-test
was used to test the treatment effect on within-subject
differences. A priori the 2-hour time point was used as
a summary measure of treatment effect. The data were
expressed as means, standard deviations (SD) and 95%
confidence intervals (CI). A p-value of < 0.05 was con-
sidered statistically significant.
Results
Twenty-three patients were recruited into the study.
A total of 19 completed the study protocol and their
baseline characteristics are displayed in Table 1. Patients
were treated with mechanical ventilation for a median
Flynn et al. Respiratory Research 2010, 11:117
http://respiratory-research.com/content/11/1/117
Page 2 of 69 days (inter-quartile range, IQR, 6-12 days). The pri-
mary underlying condition was neurological in 8
patients, medical in 4 patients, polytrauma in 6 patients
with 1 surgical patient. One patient was recruited with
an infective exacerbation of COPD.
Four patients did not have evaluable data and were
not included in the analysis. One patient became
anxious when commenced on CPAP and withdrew con-
sent (helium-oxygen), in 2 patients the respiratory rates
exceeded the protocol within 15 minutes of commen-
cing CPAP and were returned to their pre-study ventila-
tory support (1 helium-oxygen, 1 air-oxygen) and
1 patient was randomised but developed epileptic sei-
zures just prior to starting CPAP and was withdrawn.
Fifteen of the patients were studied on an FiO2 of 0.3 or
less, three patients were on an FiO2 0.35 and one
p a t i e n to na nF i O 2 of 0.4. Nine patients received
helium-oxygen mixture first compared to ten receiving
air-oxygen first.
Compared to air-oxygen, helium-oxygen significantly
decreased VCO2 production at the end of the 2 hour
period of CPAP ventilation (Figure 1) There was a mean
difference in CO2 production of 48.9 ml/min (95% CI
18.7-79.2 p = 0.003) between the groups. There were no
Table 1 Patient characteristics
Patient
number
Age Primary reason condition Secondary reason
condition
APACHE
II
Status at
unit
discharge
Length of unit
stay (rounded)
Length mechanical
ventilation till
inclusion
1 21 Status epilepticus or uncontrolled
seizures
17 Alive 11 9
2 77 Pulmonary haemorrhage not defined Thoracic or thoraco-
abdominal aortic
aneurysm
22 Alive 21 12
3 84 Inhalation pneumonitis (smoke or
gases)
19 Alive 11 12
4 44 Pneumonia, no organism isolated Depression 14 Alive 9 5
5 84 Haemorrhage or haematoma from
pelvis, long bones or joints
Fractured ribs 23 Alive 30 12
6 65 Intracerebral haemorrhage Secondary
hydrocephalus
20 Alive 5 2
7 30 Traumatic rupture or laceration of
liver
Hypovolaemic shock 16 Alive 17 13
8 68 Lung collapse or atelectasis Lung abscess 16 Alive 23 6
9 46 Primary (diffuse) brain injury Lumbar spine fracture
or ligamentous injury
25 Alive 27 26
10 47 Primary (diffuse) brain injury Amputation of limb 15 Alive 10 6
11 72 Primary (diffuse) brain injury Traumatic subarachnoid
haemorrhage
19 Alive 9 7
12 76 Abdominal aortic aneurysm, ruptured Acute renal failure due
to haemodynamic
causes
18 Dead 12 7
13 45 Primary (diffuse) brain injury Pneumonitis due to
food and vomit
10 Alive 13 10
14 18 Traumatic myocardial perforation Anoxic or ischaemic
coma or
encephalopathy
12 Alive 22 17
15 36 Tracheal trauma or perforation Traumatic
pneumothorax
19 Alive 20 12
16 28 Traumatic subdural haemorrhage Focal brain injury 9 Alive 10 8
17 58 Chronic obstructive pulmonary
disease with acute exacerbation,
unspecified
15 Alive 3 1
18 79 Traumatic subdural haemorrhage 28 Alive 6 4
19 67 Pneumonia, no organism isolated Pleural effusion 24 Alive 12 9
Mean 53.3 17.3 13.9 9.2
SD 21.7 5.0 7.6 5.7
Median 9
IQR 6-12
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CPAP with air-oxygen and helium-oxygen in all other
respiratory and heamodynamic parameters measured
(Table 2).
Discussion
Our study showed a significant reduction in CO2 pro-
duction in patients without significant airways disease.
This supports the need for a definitive clinical study of
Heliox in weaning from mechanical ventilation to be
undertaken. We were surprised by the 19% reduction in
CO2 production seen while breathing helium oxygen
although this is in keeping with a 21% reduction in work
of breathing shown by Diehl et al in their study [10]
Weaning from mechanical ventilation has a major
impact on ICU bed occupancy and patient outcome,
and has significant cost implications. Strategies to facili-
tate weaning have a major potential to improve patient
outcome and reduce the use of healthcare resources.
We demonstrate in this physiological study that patients
weaning from mechanical ventilation show a significant
r e d u c t i o ni nc a r b o nd i o x i d ep r o d u c t i o nw h e nb r e a t h i n g
a helium-oxygen mixture. We found that all other
respiratory and cardiovascular parameters measured
showed no significant changes from baseline values.
In our study we used CO2 production as a surrogate
for the work of breathing. Studies have confirmed that
inspiratory muscular work of breathing is proportional
to the exhaled volume of CO2 per minute after allowing
a period of time for stabilisation of CO2 [12-14]. Our
findings are consistent withp r e v i o u ss t u d i e su s i n g
helium-oxygen in intubated patients with COPD during
controlled ventilation and on pressure support ventila-
tion during the weaning phase of ventilation [15,16].
These studies have shown a reduction in total, resistive
and elastic work of breathing with helium-oxygen mix-
tures. In spontaneously breathing patients with COPD
during a T-piece trial there was a reduction in work of
breathing from 1.4 to 1.1 J/L in 13 patients with COPD
and a reduction in intrinsic positive end expiratory pres-
sure PEEPi [10]. Change in flow from turbulent to tran-
sitional or laminar by the use of the less dense helium is
Figure 1 Carbon dioxide production over time in hours for heliox and air.
Table 2 Respiratory and haemodynamic parameters during the study period
Baseline Helium/oxygen after 2 hours CPAP Baseline Air/oxygen after 2 hours CPAP Statistical significance
RR, breaths/min 24 +/- 7 25 +/- 5 26 +/- 6 25 +/- 6 NS
PaCO2, kPa 5.2 +/- 1.0 5.2 +/- 1.0 5.4 +/- 1.1 5.4 +/- 1.2 NS
PaO2, kPa 11.3 +/- 2.1 11.2 +/- 1.8 12.7 +/- 2.3 11.7 +/- 2.4 NS
Minute volume 10.2 +/- 2.8 10.8 +/- 2.5 10.6 +/- 2.3 10.2 +/- 2.4 NS
HR, beats/min 89 +/- 14 89 +/- 13 88 +/- 14 91 +/- 14 NS
SBP, mmHg 128 +/- 27 126 +/- 23 126 +/- 23 130 +/- 27 NS
DBP, mmHg 63 +/- 8 62 +/- 10 63 +/- 11 65 +/- 12 NS
Temperature 37 +/- 1 37 +/- 1 37+/- 1.5 37 +/- 1 NS
Definitions of abbreviations; RR = respiratory rate; HR = heart rate; SBP = systolic blood pressure; DBP = diastolic blood pressure; NS = non significant.
Values are means +/- standard deviation
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flow. However, a study by Papamoschou, demonstrated
that helium-oxygen does not need to be laminar to
improve flow and benefits exist even if flow remains
turbulent [7]. In a study in 18 patients without COPD
studied immediately post-extubation, helium-oxygen
given for 15 minutes reduced inspiratory effort as mea-
sured by transdiaphragmatic pressure changes. A signifi-
cant subjective improvement in respiratory comfort was
also observed. This benefit reversed when patients were
returned to air-oxygen [17]. However as patients were
already weaned to the point of extubation, no conclu-
sion can be drawn as to whether helium-oxygen
improved the weaning phase. A further small study of
helium use in infants post-cardiac surgery, during wean-
ing, showed a reduction in CO2 production and an
increase in PaO2 reflecting a reduction in work of
breathing [9]. Our current study extends these previous
data to a group of general adult intensive care unit
patients without significant airways disease during the
weaning phase of mechanical ventilation. While this
physiological study has demonstrated a beneficial but
transient effect on CO2 production with the short-term
use of a helium mixture, future studies designed to
investigate the effect on duration of weaning would
require longer term use of helium mixture.
It is worth noting that helium can interfere with the
function of ventilators and in particular, flow measure-
ment devices. It is therefore important that clinicians
are aware of the effects helium can have on the equip-
ment they use, and equipment must be compatible with,
and calibrated for, use with helium [18].
This study has several limitations. The aim of this
physiological study was to measure CO2 production
in patients without documented obstructive airways
disease. It is not possible to exclude that a proportion of
the patients had unrecognised small airways obstruction.
The study is limited by the small number of patients
and one patient had a documented history of COPD.
Importantly when this patient is removed from the
analysis the beneficial effect of helium-oxygen is still
significant. In addition, we used CO2 production as a
surrogate for work of breathing. Carbon Dioxide pro-
duction is one of the indirect calorimetric methods of
measuring metabolic rate. Factors other than work of
breathing that increase metabolic rate will likely increase
CO2 production. No changes to the physical workload
of our patients were made during the study period.
Furthermore there was no difference in other measured
respiratory and haemodynamic parameters or tempera-
ture as shown in Table 2. This indirectly indicates that
the change in CO2 production is likely to indirectly
reflect work of breathing. Measurements of trans-
oesophageal pressures or pressure-volume loop would
have been useful to more directly assess work of breath-
ing but unfortunately these were not available.
In conclusion, our study demonstrated a significant
reduction in CO2 production, as a surrogate measure of
work of breathing, in adult patients during the weaning
phase of ventilation breathing a helium-oxygen mixture.
This provides support for a clinical study powered for
duration of weaning as the primary outcome to be
undertaken.
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